Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03216512 · ClinicalTrials.gov registry record · NA

Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD

A NA study of ADHD, sponsored by Duke University.

Completed
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT03216512 is a NA study of ADHD that has completed, run by Duke University. The registered enrollment target is 36 participants, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03216512, a NA study of ADHD, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate performance on the Attention Deficit Hyperactivity Disorder ( ADHD) Battery of the Cambridge Automated Neuropsychological Test Battery (CANTAB), including spatial working memory, inhibitory control, and attention while using either a noise cancelling headphone or sham headphone control in the presence of standardized auditory distractors in children and adolescents with ADHD.

Conditions Studied

Interventions

  • OTHER Use of Noise Cancelling Headphones

Study Locations (1)

North Carolina

  • Duke Child and Family Study Center - Durham

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2018-09-21
Est. Completion 2019-01-31
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT03216512

The ClinicalTrials.gov registry entry for NCT03216512 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (81% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 1 intervention - of which Use of Noise Cancelling Headphones is the first listed.

NCT03216512 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03216512 about?

NCT03216512 is a clinical study titled "Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD". The purpose of this study is to evaluate performance on the Attention Deficit Hyperactivity Disorder ( ADHD) Battery of the Cambridge Automated Neuropsychological Test Battery (CANTAB), including spatial working memory, inhibitory control, and attention while using either a noise cancelling headphon...

What is the current status of trial NCT03216512?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2018-09-21. Estimated completion is 2019-01-31.

What conditions does trial NCT03216512 study?

This clinical trial studies the following conditions: ADHD.

What interventions are being tested in trial NCT03216512?

The interventions under investigation include: Use of Noise Cancelling Headphones (OTHER).

Who is sponsoring clinical trial NCT03216512?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03216512 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ADHD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.